Overall rank by patents
#47,145
Across all tracked assignees
USPTO PatentsView assignee record - 5 granted patents across 8 technology areas, active 2016–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H01F (MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES).
The verdict
Gedex holds 5 US patents across 8 technology areas, rank #47,145 of 50,000 tracked assignees.
Gedex Systems Inc. has been granted 5 US utility patents between 2016 and 2019, placing Gedex Systems Inc. at rank #47,145 across all assignees tracked by PlainPatent. This portfolio spans 8 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.2 claims per patent with primary concentration in H01F (MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES). As a Foreign Corporation, Gedex Systems Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Gedex sits between Gateway Safety, Inc. (5 patents, rank #47,141) and Gene Therapy Systems, Inc. (5 patents, rank #47,149) - the closest US assignees by grant volume. The composite Innovation Score of 28.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 5 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Gedex Systems Inc.'s 21.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 8 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Gedex Systems Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Gateway Safety, Inc.
5 patents
Gautschi Engineering GmbH
5 patents
Ge Solartech, LLC
5 patents
Gebhardt Foerdertechnik GmbH
5 patents
Gelmart Industries, Inc.
5 patents
GemEx Systems, Inc.
5 patents
GenFleet Therapeutics (Shanghai) Inc.
5 patents
Gene Therapy Systems, Inc.
5 patents
Gedex Systems Inc.
5 patents
What this shows Gedex holds 5 patents at rank #47,145, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #47,145 in granted patent volume.
Other assignees with the most granted patents in Gedex's primary technology class.
Gedex's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 71% higher than 29% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 20.0% |
| 2017 | 2 | 40.0% |
| 2019 | 2 | 40.0% |
Top 8 of 8 technology areas
Overall rank by patents
#47,145
Across all tracked assignees
28.9 out of 100
How to use this portfolio
Gedex's 5 grants land it in the top 71% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.